Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-217.5%
operating margin TTM
-153.2%
revenue TTM
1.23 Million
revenue per share TTM
0.27$
valuation ratios | |
|---|---|
| pe ratio | -0.15 |
| peg ratio | -0.53 |
| price to book ratio | 0.31 |
| price to sales ratio | 1.39 |
| enterprise value multiple | -1.04 |
| price fair value | 0.31 |
profitability ratios | |
|---|---|
| gross profit margin | 23.92% |
| operating profit margin | -153.2% |
| pretax profit margin | -216.89% |
| net profit margin | -217.5% |
| return on assets | -134.47% |
| return on equity | -380.78% |
| return on capital employed | -128.9% |
liquidity ratios | |
|---|---|
| current ratio | 2.60 |
| quick ratio | 2.58 |
| cash ratio | 2.22 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 3.79 |
| operating cycle | 32.98 |
| days of payables outstanding | 53.94 |
| cash conversion cycle | -20.96 |
| receivables turnover | 12.50 |
| payables turnover | 6.77 |
| inventory turnover | 96.28 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.11 |
| debt equity ratio | 0.16 |
| long term debt to capitalization | 0.10 |
| total debt to capitalization | 0.14 |
| interest coverage | -184.25 |
| cash flow to debt ratio | -7.28 |
cash flow ratios | |
|---|---|
| free cash flow per share | -7.98 |
| cash per share | 6.05 |
| operating cash flow per share | -7.92 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -7.28 |
| short term coverage ratios | -22.00 |
| capital expenditure coverage ratio | -139.46 |
Frequently Asked Questions
When was the last time bioAffinity Technologies, Inc. (NASDAQ:BIAF) reported earnings?
bioAffinity Technologies, Inc. (BIAF) published its most recent earnings results on 14-11-2025.
What is bioAffinity Technologies, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. bioAffinity Technologies, Inc. (NASDAQ:BIAF)'s trailing twelve months ROE is -380.78%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. bioAffinity Technologies, Inc. (BIAF) currently has a ROA of -134.47%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did BIAF's net profit margin stand at?
BIAF reported a profit margin of -217.5% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is BIAF's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.60 in the most recent quarter. The quick ratio stood at 2.58, with a Debt/Eq ratio of 0.16.